THE NEED FOR EXTENDED-RELEASE MEDICATIONS

被引:1
作者
ALEXANDER, PE [1 ]
机构
[1] PSYCHIAT FDN RES EDUC INC, WARWICK, RI USA
来源
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 1995年 / 56卷 / 09期
关键词
D O I
10.1016/0011-393X(95)85099-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Because of their relatively short duration of action, most benzodiazepine anxiolytics require multiple daily dosing (two to four times per day) to maintain a consistent therapeutic benefit. The need for multiple daily doses can lead to interdose anxiety or brief periods of excessive side effects. These difficulties can both precipitate and exacerbate poor compliance with prescribed regimens. A new extended-release formulation of alprazolam (alprazolam XR) consistently maintains drug concentrations within the therapeutic range during a 12- to 24-hour duration of action. The potential advantages of alprazolam XR include improved compliance, less interdose anxiety, and a reduced risk of side effects.
引用
收藏
页码:940 / 946
页数:7
相关论文
共 14 条
[11]  
SHADER RI, 1991, J CLIN PSYCHOPHARM, V11, P153
[12]  
SHEEHAN DV, 1993, PSYCHIAT ANN, P3
[13]   CLINICAL PHARMACOKINETICS OF ALPRAZOLAM EXTENDED-RELEASE - A SUMMARY [J].
WRIGHT, CE .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1995, 56 (09) :947-956
[14]  
1992, BRIT J PSYCHIAT, V160, P191